戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  immunization rates and prevent outbreaks of vaccine-preventable disease.
2  risk for morbidity and mortality related to vaccine-preventable disease.
3  the rates of effective immunization against vaccine preventable diseases.
4 ment of global health through elimination of vaccine preventable diseases.
5 nt 'immunity,' as is commonly done for other vaccine preventable diseases.
6 ich may leave communities more vulnerable to vaccine-preventable diseases.
7 ts with IBD may be at increased risk of some vaccine-preventable diseases.
8 sease (IBD) may be at increased risk of some vaccine-preventable diseases.
9 de remarkable achievements in the control of vaccine-preventable diseases.
10 suffering and deaths from existing and novel vaccine-preventable diseases.
11 neously promoting immunisation against other vaccine-preventable diseases.
12  unstable regions threatens progress against vaccine-preventable diseases.
13 nd yet millions of people die each year from vaccine-preventable diseases.
14 disability, and death from measles and other vaccine-preventable diseases.
15 sed acceptance of vaccines and resurgence of vaccine-preventable diseases.
16 ng to 1.5 million child deaths annually from vaccine-preventable diseases.
17 s that would put children at higher risk for vaccine-preventable diseases.
18 eity in the proportion of children immune to vaccine-preventable diseases.
19 h immunization rates to prevent outbreaks of vaccine-preventable diseases.
20 's population from accessing protection from vaccine-preventable diseases.
21 tform-enabling technology applicable to most vaccine-preventable diseases.
22 otential to sustain epidemic transmission of vaccine-preventable diseases.
23 t the pregnant woman, fetus, and infant from vaccine-preventable diseases.
24 tion of all children and adolescents against vaccine-preventable diseases.
25  about vaccines, vaccination programmes, and vaccine-preventable diseases.
26 address HIV/AIDS, malaria, tuberculosis, and vaccine-preventable diseases.
27 to provide advice and guidance on control of vaccine-preventable diseases.
28 ical exemptions can affect community risk of vaccine-preventable diseases.
29 creased risk of contracting and transmitting vaccine-preventable diseases.
30 ve vaccine efficacy and broaden the range of vaccine-preventable diseases.
31 f cases, deaths, and hospitalizations for 13 vaccine-preventable diseases.
32                   The leading causes include vaccine-preventable diseases.
33 t ensure adequate protection against certain vaccine-preventable diseases.
34 ies to ensure control of pertussis and other vaccine-preventable diseases.
35  and is similar to that seen for other viral vaccine-preventable diseases.
36 tial of new vaccines into the reality of new vaccine-preventable diseases.
37 n and the leading cause of child death among vaccine-preventable diseases.
38        Rotavirus is now a commonly occurring vaccine-preventable disease among children in developed
39                                  The risk of vaccine-preventable diseases among children who have phi
40  NmB were relatively low compared with other vaccine-preventable diseases and might be decreasing.
41 rveillance as a platform for surveillance of vaccine-preventable diseases and other outbreak-prone di
42        Critical outcomes included mortality, vaccine-preventable diseases, and serious adverse events
43 to this achievement, but with a reduction in vaccine preventable diseases, anti-vaccine sentiments ha
44 n complacency occurs when perceived risks of vaccine-preventable diseases are sufficiently low so tha
45                                        Other vaccine-preventable diseases are unlikely to reestablish
46 ontinues to sustain a considerable burden of vaccine-preventable diseases because of incomplete vacci
47 seline disease incidence can lead to a large vaccine-preventable disease burden and thus that populat
48 countries represented the majority of global vaccine-preventable disease burden.
49 cohorts and interrupted progress in reducing vaccine-preventable disease burden.
50        Leishmaniasis is widely regarded as a vaccine-preventable disease, but the costs required to r
51           Adults are at substantial risk for vaccine-preventable disease, but their vaccination rates
52                                              Vaccine-preventable diseases cause more than 1 million d
53                            As a prototypical vaccine-preventable disease, cholera continues to be an
54 wer odds of seropositivity to SARS-CoV-2 and vaccine preventable diseases compared to urban clusters.
55 tical role in describing the epidemiology of vaccine-preventable diseases, contributing to developmen
56 the implications of subpopulations for other vaccine-preventable disease eradication efforts.
57 t the reemerging threat of measles and other vaccine-preventable diseases, findings such as ours can
58  that patients lose protective antibodies to vaccine-preventable diseases following allogeneic BMT an
59 United States target an increasing number of vaccine-preventable diseases for reduction, elimination,
60 n of national vaccine recommendations for 13 vaccine-preventable diseases for which recommendations w
61 ease processes such as emerging zoonoses and vaccine-preventable diseases, [Formula: see text] and in
62 ntial progress in reduction of the burden of vaccine-preventable diseases has been made, continued ca
63 unization and subsequent recent outbreaks of vaccine-preventable diseases have been spawned by severa
64 es less than 20 years ago, measles and other vaccine-preventable diseases have made a spectacular com
65 ntially more deaths in CYP annually than any vaccine-preventable disease historically in the recent p
66 World Health Organization Invasive Bacterial-Vaccine Preventable Diseases (IB-VPD) surveillance in Su
67  it remains one of the least well-controlled vaccine-preventable diseases, illustrating the shortcomi
68  Hepatitis A is the most frequently reported vaccine-preventable disease in the United States.
69                 Influenza is the most common vaccine-preventable disease in the United States; howeve
70 pulations in conflict settings, outbreaks of vaccine-preventable disease in these settings may persis
71 t, there is an increase in the prevalence of vaccine-preventable diseases in low-income countries eve
72                          Recent outbreaks of vaccine-preventable diseases in the United States have d
73 on requirements are important in controlling vaccine-preventable diseases in the United States.
74 ents have played a major role in controlling vaccine-preventable diseases in the United States.
75 o quantify this underestimation, we compared vaccine-preventable disease incidence (VPDI) of clinical
76                              Despite being a vaccine-preventable disease, influenza-related complicat
77                  The number of cases of most vaccine-preventable diseases is at an all-time low; hosp
78 8 pathogens using a multiplex bead assay for vaccine preventable diseases, malaria, SARS-CoV-2, negle
79                   Wastewater surveillance of vaccine-preventable diseases may provide early warning o
80                 Since 2016, outbreaks of the vaccine-preventable diseases measles and diphtheria have
81 out adjustment for factors that could affect vaccine-preventable disease morbidity, mortality, or rep
82 considerable reduction in total YLLs in many vaccine-preventable diseases, most notably diphtheria, p
83                      Eradication efforts for vaccine-preventable diseases need to create performance
84  Organization coordinated Invasive Bacterial Vaccine Preventable Diseases network, Togo conducts surv
85                            1) focus on other vaccine preventable diseases, not COVID-19 and 2) discus
86 in immunization for the three most important vaccine preventable diseases of aging.
87 lear path to avoiding outbreaks of childhood vaccine-preventable diseases once the threat of Ebola be
88 mmunisation disruption evokes the dangers of vaccine-preventable disease outbreaks in the future.
89 accination in Michigan to assess the risk of vaccine-preventable disease outbreaks in the state, yet
90 d healthcare system-can increase the risk of vaccine-preventable disease outbreaks like measles.
91 ch will be essential to minimise the risk of vaccine-preventable disease outbreaks, reach children wh
92 istrict levels in areas deemed high risk for vaccine-preventable disease outbreaks.
93 h the highest cost of illness averted of any vaccine-preventable disease (Ozawa et al., Bull.
94 lth Organization Technical Advisory Group on Vaccine Preventable Diseases recommended the implementat
95 reasons the 1997 Technical Advisory Group on Vaccine-Preventable Diseases recommended acceleration of
96 ys in receiving vaccinations lead to greater vaccine-preventable disease risk.
97  reducing morbidity and mortality from other vaccine-preventable diseases, should provide hope that p
98 does the risk and occurrence of outbreaks of vaccine-preventable diseases such as measles.
99         Declines in vaccination coverage for vaccine-preventable diseases, such as measles and chicke
100 ndas in Nigeria, particularly the control of vaccine-preventable diseases, such as measles.
101    Barriers to childhood vaccination against vaccine-preventable diseases, such as those due to human
102 grating measles, neonatal tetanus, and other vaccine-preventable disease surveillance and their respe
103 with the World Health Organization's updated vaccine-preventable disease surveillance standards and i
104 alth Organization's (WHO) Invasive Bacterial Vaccine-preventable Diseases Surveillance Network (2011-
105  80% or greater for cases and deaths of most vaccine-preventable diseases targeted since 1980 includi
106                      Although influenza is a vaccine-preventable disease that annually causes substan
107            Chickenpox is a highly contagious vaccine-preventable disease that can lead to severe comp
108                      Seasonal influenza is a vaccine-preventable disease that remains a major health
109       This issue is relevant to pertussis, a vaccine-preventable disease that remains a significant p
110                                 Tetanus is a vaccine-preventable disease that still commonly occurs i
111 omising strategy for the prevention of other vaccine-preventable diseases that threaten pregnant wome
112 odel to other global laboratory networks for vaccine-preventable diseases that will endure after the
113  Americans from COVID-19, measles, and other vaccine-preventable diseases to anti-science.
114 orces the need for enhanced surveillance for vaccine-preventable diseases to determine the prevalence
115 onnel are at increased risk for transmitting vaccine-preventable diseases to their patients.
116 213, 95% CI [3.205, 3.220]; p < 0.001) among vaccine-preventable diseases, tuberculosis (IRR: 1.011,
117  the mortality and morbidity associated with vaccine-preventable diseases, vaccination uptake remains
118  We aimed to estimate population immunity to vaccine-preventable diseases (VPDs) after vaccination ac
119                                 Outbreaks of vaccine-preventable diseases (VPDs) in healthcare worker
120                                              Vaccine-preventable diseases (VPDs) remain major causes
121 oordinates global laboratory surveillance of vaccine-preventable diseases (VPDs), including polio, me
122                            During 1946-2005, vaccine-preventable diseases were the topic of approxima
123 e an under-immunised group globally for many vaccine-preventable diseases, with data showing that the
124 ntestinal and foodborne infectious diseases, vaccine-preventable diseases, zoonotic and vectorborne d

 
Page Top